MedPath

A human study for investigating the effectiveness of Lactobacillus plantarum Q180 on control of triglyceride level

Not Applicable
Conditions
Endocrine, nutritional and metabolic disease
Registration Number
KCT0002085
Lead Sponsor
Chong Kun Dang Bio
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot yet recruiting
Sex
All
Target Recruitment
80
Inclusion Criteria

1) Subject who voluntarily agrees to participate and sign in informed consent form
2) Man and postmenopausal women (45 years = Age )
3) Fasting triglyceride level =150mg/dL and <200mg/dL

Exclusion Criteria

1) Recommended Food Score > 36
2) BMI < 23kg/m2 or > 35 kg/m2
3) high-intensity exercise regularly (=10 hours/week)
4) Chronic smokers (=20cigarettes/day)
5) Alcoholics or drinking quantity: Alcohol 420g/week (soju about 7 bottles/week)
6) follwing disease or personal history
hyperlipidemia, diabetes mellitus, hypertension, liver complaint, enteropathy(including ulcerative colitis, lactose intolerance), renal disease, cardiovascular disease, cerebrovascular disease, pancreatitis, cancer, thyroid gland disease, dementia, Parkinson's disease, depressive disorder, anorexia nervosa/polyphagia, multiple sclerosis, Spinal cord injury
7) Volunteer who has taken follwing drug within 1.5 months or during study period : Lipid Lowering Agent(Ursodeoxycholic acid, statin etc), antidiabetics, antibiotics, durg affecting Intestinal Functions, hormone, oral contraception, durg affecting lipid metabolism.
8) Volunteer who has taken herbal medicine within 2 months.
9) Volunteer who has taken probiotics, prebiotics, dietary supplements that affect the body fat, lipid metabolism or intestinal health within 1 months.
10) Volunteer who are hypersensitivity to dietary supplement or ingredients contained in the supplement.
11) Volunteer who has been in clinical demonstration within 3 months.
12) pregnant woman or lactating women
13) Volunteer who judged incongruent by tester through clinical examination center.

Study & Design

Study Type
Interventional Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Lipid Levels and Related metabolic indicators
Secondary Outcome Measures
NameTimeMethod
gene expression relating lipid metabolism;Anthropometric Measurement ;bowel habits;intestinal health index (stool metabolome(monoenoic fatty acid, indole, phenol, biogenic amines), Harmful/beneficial bacteria identification)
© Copyright 2025. All Rights Reserved by MedPath